Table 7 Overview of most commonly reported AEs
Carrageenan (n = 126) | Placebo (n = 128) | Total (n = 254) | ||||
|---|---|---|---|---|---|---|
n | % | n | % | n | % | |
N. of patients without AEs | 103 | 81,7% | 99 | 77,3% | 202 | 79,5% |
Cough | 1 | 0,8% | 4 | 3,1% | 5 | 2,0% |
Rhinitis* | 0 | 0,0% | 4 | 3,1% | 4 | 1,6% |
Otitis media | 3 | 2,4% | 1 | 0,8% | 4 | 1,6% |
Nasal bleeding | 3 | 2,4% | 1 | 0,8% | 4 | 1,6% |
Fever, infection NOS** | 2 | 1,6% | 2 | 1,6% | 4 | 1,6% |
Bronchitis | 2 | 1,6% | 2 | 1,6% | 4 | 1,6% |
Nasal disorders NOS*** | 1 | 0,8% | 2 | 1,6% | 3 | 1,2% |
Vomiting | 1 | 0,8% | 1 | 0,8% | 2 | 0,8% |
Tonsillitis | 2 | 1,6% | 0 | 0,0% | 2 | 0,8% |
Sinusitis | 0 | 0,0% | 2 | 1,6% | 2 | 0,8% |
Rash | 0 | 0,0% | 2 | 1,6% | 2 | 0,8% |
Nausea | 0 | 0,0% | 2 | 1,6% | 2 | 0,8% |
Ear pain | 1 | 0,8% | 1 | 0,8% | 2 | 0,8% |
Conjunctivitis | 1 | 0,8% | 1 | 0,8% | 2 | 0,8% |
Adenoids | 1 | 0,8% | 1 | 0,8% | 2 | 0,8% |
Abdominal pain | 1 | 0,8% | 1 | 0,8% | 2 | 0,8% |